| DIRECT COMPETITOR COMPARISON | |
| CLDX | DNDN | GTOP.PK | NWBO.OB | Industry | | Market Cap: | 145.05M | 3.50B | N/A | 46.45M | 53.34M | | Employees: | 78 | 198 | N/A | 4 | 70 | | Qtrly Rev Growth (yoy): | 70.90% | -3.80% | N/A | 0.00% | 18.90% | | Revenue (ttm): | 13.44M | 108.00K | N/A | 10.00K | 12.73M | | Gross Margin (ttm): | 100.00% | 100.00% | N/A | 100.00% | 50.90% | | EBITDA (ttm): | -28.69M | -74.09M | N/A | -16.53M | -1.76M | | Oper Margins (ttm): | -233.99% | -72,917.59% | N/A | -165,480.00% | -7.52% | | Net Income (ttm): | -31.04M | -196.49M | N/A | -26.15M | N/A | | EPS (ttm): | -1.961 | -1.915 | N/A | -0.594 | N/A | | P/E (ttm): | N/A | N/A | N/A | N/A | 26.58 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 1.39 | | P/S (ttm): | 10.96 | 31571.36 | N/A | 4644.64 | 3.17 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.27 | -0.92% | 56.95B | 12.27 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 52.99 | -0.82% | 15.32B | 17.73 | | Genzyme Corp. | GENZ | 51.13 | 4.41% | 13.57B | 29.15 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 44.87 | 0.25% | 40.38B | 17.35 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.25 | -2.23% | 9.14B | 1045.92 | | Teva Pharmaceutical Industries Limited | TEVA | 56.84 | -0.63% | 50.08B | 52.00 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.70 | -0.80% | 4.21B | 20.46 | | King Pharmaceuticals Inc. | KG | 12.73 | 0.39% | 3.16B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.03 | -1.69% | 5.51B | 110.61 | | Pfizer Inc. | PFE | 18.53 | -0.38% | 149.53B | 15.39 | | Johnson & Johnson | JNJ | 63.99 | -0.71% | 176.55B | 13.97 | | GlaxoSmithKline plc | GSK | 41.48 | 0.34% | 105.15B | 13.56 | | Sanofi-Aventis | SNY | 40.06 | -0.55% | 104.60B | N/A | | Novartis AG | NVS | 51.91 | -0.88% | 117.90B | 15.54 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 43.09 | -1.22% | N/A | N/A | | AstraZeneca plc | AZN | 46.58 | 1.09% | 67.54B | 9.35 | | Abbott Laboratories | ABT | 54.77 | 0.83% | 84.71B | 14.84 | | Bristol-Myers Squibb Co. | BMY | 25.24 | 0.08% | 50.00B | 13.06 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|